Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery
A hybrid of zeolite Y-gelatin film as an oral dosage form for the natural anticancer drug was achieved by homogenously incorporating the drug-loaded zeolite Y into the gelatin solution. Drug ability was analyzed using computational and experimental approaches, drug encapsulation efficiency via the B...
Published in: | Journal of Advanced Research in Micro and Nano Engineering |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Penerbit Akademia Baru
2024
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85193724730&doi=10.37934%2farmne.18.1.3243&partnerID=40&md5=fd9d6d30ba210fc4d131f6d73ab2252a |
id |
2-s2.0-85193724730 |
---|---|
spelling |
2-s2.0-85193724730 Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R. Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery 2024 Journal of Advanced Research in Micro and Nano Engineering 18 1 10.37934/armne.18.1.3243 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85193724730&doi=10.37934%2farmne.18.1.3243&partnerID=40&md5=fd9d6d30ba210fc4d131f6d73ab2252a A hybrid of zeolite Y-gelatin film as an oral dosage form for the natural anticancer drug was achieved by homogenously incorporating the drug-loaded zeolite Y into the gelatin solution. Drug ability was analyzed using computational and experimental approaches, drug encapsulation efficiency via the BET method, and possible interactions by FTIR analyses. Zerumbone released was done in both pH 1.2 and pH 7.4 mimicking the human gastrointestinal tract conditions for 24 hrs and subjected to kinetics study via suitable mathematical models to determine what governs the drug release with the results indicating that a sustained delivery of once-daily oral dosage form could be achieved. © 2024, Penerbit Akademia Baru. All rights reserved. Penerbit Akademia Baru 27568210 English Article All Open Access; Hybrid Gold Open Access |
author |
Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R. |
spellingShingle |
Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R. Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery |
author_facet |
Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R. |
author_sort |
Salleh N.; Mahat M.M.; Yahaya S.M.; Ramli R. |
title |
Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery |
title_short |
Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery |
title_full |
Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery |
title_fullStr |
Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery |
title_full_unstemmed |
Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery |
title_sort |
Kinetic and Mechanism of Zerumbone Release from Cross-linked Gelatin-Zeolite Y Hybrid for Oral Anticancer Drug Delivery |
publishDate |
2024 |
container_title |
Journal of Advanced Research in Micro and Nano Engineering |
container_volume |
18 |
container_issue |
1 |
doi_str_mv |
10.37934/armne.18.1.3243 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85193724730&doi=10.37934%2farmne.18.1.3243&partnerID=40&md5=fd9d6d30ba210fc4d131f6d73ab2252a |
description |
A hybrid of zeolite Y-gelatin film as an oral dosage form for the natural anticancer drug was achieved by homogenously incorporating the drug-loaded zeolite Y into the gelatin solution. Drug ability was analyzed using computational and experimental approaches, drug encapsulation efficiency via the BET method, and possible interactions by FTIR analyses. Zerumbone released was done in both pH 1.2 and pH 7.4 mimicking the human gastrointestinal tract conditions for 24 hrs and subjected to kinetics study via suitable mathematical models to determine what governs the drug release with the results indicating that a sustained delivery of once-daily oral dosage form could be achieved. © 2024, Penerbit Akademia Baru. All rights reserved. |
publisher |
Penerbit Akademia Baru |
issn |
27568210 |
language |
English |
format |
Article |
accesstype |
All Open Access; Hybrid Gold Open Access |
record_format |
scopus |
collection |
Scopus |
_version_ |
1809677881256706048 |